These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6652878)

  • 21. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Eur J Pharmacol; 1984 Jan; 97(1-2):37-46. PubMed ID: 6698110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N; Siegfried M; Tsao P; Lento P; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of ethylketocyclazocine in hemorrhagic shock.
    Curtis MT; Lefer AM
    Adv Shock Res; 1983; 10():101-9. PubMed ID: 6308972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of splanchnic artery occlusion (SAO) shock by cysteine.
    Galvin MJ; Lefer AM
    Adv Shock Res; 1978; 1():261-70. PubMed ID: 262085
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.
    Stahl GL; Bitterman H; Lefer AM
    Thromb Res; 1989 Feb; 53(3):327-38. PubMed ID: 2718150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
    Levitt MA; Stahl G; Lefer AM
    Resuscitation; 1988 Jul; 16(3):211-20. PubMed ID: 2845544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock.
    Terashita Z; Stahl GL; Lefer AM
    J Cardiovasc Pharmacol; 1988; 12(5):505-11. PubMed ID: 2468048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective action of 6-keto-prostaglandin E1 in traumatic shock.
    Araki H; Lefer AM
    Prostaglandins Med; 1979 Apr; 2(4):277-84. PubMed ID: 575862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H; Stahl GL; Lefer AM
    Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dopaminergic effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats].
    Zou AP; Parekh N; Steinhausen M
    J Tongji Med Univ; 1991; 11(2):65-72. PubMed ID: 1687750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salutary actions of nimodipine in traumatic shock.
    Lefer AM; Carrow BA
    Life Sci; 1981 Sep; 29(13):1347-53. PubMed ID: 7289786
    [No Abstract]   [Full Text] [Related]  

  • 35. The pharmacological properties of anisodamine.
    Poupko JM; Baskin SI; Moore E
    J Appl Toxicol; 2007; 27(2):116-21. PubMed ID: 17186568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of the protective effect of conditioning in rats subjected to Noble-Collip drum trauma.
    Galvin MJ; Sollott SJ; Lefer AM
    Circ Shock; 1979; 6(1):23-9. PubMed ID: 455590
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock.
    Johnson G; Lefer AM
    Circ Shock; 1990 Feb; 30(2):155-64. PubMed ID: 2311204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salutary effects of prostacyclin in endotoxic shock.
    Lefer AM; Tabas J; Smith EF
    Pharmacology; 1980; 21(3):206-12. PubMed ID: 6997895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental studies on the effect of anisodamine (654-2) on endotoxic shock].
    Chen XY; Yan YZ; Xi PX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Aug; 9(4):250-4. PubMed ID: 2964929
    [No Abstract]   [Full Text] [Related]  

  • 40. Anisodamine as an effective drug to treat snakebites.
    Li QB; Pan R; Wang GF; Tang SX
    J Nat Toxins; 1999 Oct; 8(3):327-30. PubMed ID: 10591035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.